0.07%| Prev Close: | 2.60 |
|---|---|
| Open: | 2.61 |
| Bid: | 2.40 x 400 |
| Ask: | 2.44 x 1200 |
| 1y Target Est: | 4.94 |
| Beta: | 1.59 |
| Next Earnings Date: | N/A |
| Day's Range: | 2.52 - 2.61 |
|---|---|
| 52wk Range: | 1.17 - 3.00 |
| Volume: | 845,073 |
| Avg Vol (3m): | 1,997,640 |
| Market Cap: | 212.49M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.27 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Galena Biopharma to Present at the 2013 Marcum MicroCap ConferenceGlobeNewswire(Thu May 23)
- Investors Begin To Realize RNA’s PotentialAccesswire(Tue May 21)
- A Journey To Add Biotech To The Portfolioat Seeking Alpha(Sat May 18)
- GALENA BIOPHARMA, INC. FinancialsEDGAR Online Financials(Fri May 17)
- GALENA BIOPHARMA, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and ExEDGAR Online(Thu May 16)
- Galena Targets Cancer Pain Marketat Seeking Alpha(Wed May 15)
- Alexza Pharmaceuticals: A Teva Partnership Of Immense Meaningat Seeking Alpha(Wed May 15)
- Galena Biopharma: Stock First, Science Second?at Seeking Alpha(Mon May 13)
- VIDEO RELEASE -- Galena Biopharma Reports First Quarter 2013 Financial ResultsGlobeNewswire(Thu May 9)
- GALENA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExEDGAR Online(Thu May 9)
- Galena Biopharma's Abstral serves as model for TIRF REMS programtheflyonthewall.com(Thu May 9)
- Galena Biopharma Poster Presentation at the American Pain Society 32nd Annual Scientific MeetingGlobeNewswire(Thu May 9)
- Galena: Improving Cancer Vaccines for the Futureat Motley Fool(Tue May 7)
- Top Small-Cap Biotech Stocks Being Accumulated By Large Fund Managersat Seeking Alpha(Tue May 7)
- 2 Biotechs To Avoid, 1 To Buyat Motley Fool(Sat May 4)
Press Releases
- Investors Begin To Realize RNA’s PotentialAccesswire(Tue May 21)
- NASDAQ Stocks Announcements On: (NASDAQ: GALE), (NASDAQ: MNKD)Accesswire(Mon Apr 22)
- Vital Trend Analysis Reports For Traders And Investors On: (NASDAQ: IDIX), (NASDAQ: GALE)Accesswire(Thu Nov 29)
Must Read
- Closed business in Corner Brook an eyesore, says board of tradeCBC(Sat 5:56AM EDT)
- News Corp. board approves poison pill, $500 million stock buyback before splitThe Canadian Press(Fri May 24)
- National Bank considering new acquisitions in Canadian wealth managementThe Canadian Press(Fri May 24)
- MTS to sell Allstream to Egyptian investment group, focus on Manitoba marketThe Canadian Press(Fri May 24)
- Loonie lower despite positive durable goods data, little else on calendarThe Canadian Press(Fri May 24)